These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2289831)

  • 1. Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients.
    Caruana RJ; Lobel SA; Leffell MS; Campbell H; Cheek PL
    Int J Artif Organs; 1990 Dec; 13(12):794-8. PubMed ID: 2289831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.
    Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U
    Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.
    Herbelin A; Nguyen AT; Zingraff J; Ureña P; Descamps-Latscha B
    Kidney Int; 1990 Jan; 37(1):116-25. PubMed ID: 2299797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes.
    Klinke B; Röckel A; Abdelhamid S; Fiegel P; Walb D
    Int J Artif Organs; 1989 Nov; 12(11):697-702. PubMed ID: 2689356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
    Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
    Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins.
    Mege JL; Sanguedolce MV; Purgus R; Moulin B; Bongrand P; Capo C; Olmer M
    Am J Kidney Dis; 1992 Nov; 20(5):482-8. PubMed ID: 1279968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis.
    Canivet E; Lavaud S; Wong T; Guenounou M; Willemin JC; Potron G; Chanard J
    Am J Kidney Dis; 1994 Jan; 23(1):41-6. PubMed ID: 8285196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels.
    Anderson J; Briefel G; Jones JM; Ryu JH; McGuire M; Yun YP
    Kidney Int; 1991 Dec; 40(6):1110-7. PubMed ID: 1762311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.
    Jörres A; Safak H; Froese P; Fischer C; Müller C; Gahl GM; Vienken J
    Artif Organs; 1992 Dec; 16(6):559-63. PubMed ID: 1482324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis.
    Jörres A; Froese P; Fischer C; Safak H; Gahl GM; Müller C; Vienken J
    Int J Artif Organs; 1992 Nov; 15(11):653-7. PubMed ID: 1490756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin.
    Pertosa G; Marfella C; Tarantino EA; Di Cillo M; Manno C; Russo R; Schena FP
    Nephrol Dial Transplant; 1991; 6 Suppl 2():18-23. PubMed ID: 1866063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biocompatibility study--inflammable cytokine production by the extract from fiber membrane in human peripheral blood].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):496-503. PubMed ID: 7969016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of membrane characteristics on tumour necrosis factor kinetics during haemodialysis.
    Ghysen J; De Plaen JF; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1990; 5(4):270-4. PubMed ID: 2113223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.